4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Imp

Cui, Huarui; Carlson, Angela S.; Schleiff, Mary A.; Divakaran, Anand; Johnson, Jorden A.; Buchholz, Caroline R.; Zahid, Huda; Vail, Nora R.; Shi, Ke; Aihara, Hideki; Harki, Daniel A.; Miller, Grover P.; Topczewski, Joseph J.; Pomerantz, William C.K.

doi:10.1021/acs.jmedchem.1c00933

4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Imp

Journal Article · 01 July 2021 · J. Med. Chem.

DOI:https://doi.org/10.1021/acs.jmedchem.1c00933· OSTI ID:1818348

Cui, Huarui; Carlson, Angela S.; Schleiff, Mary A.; Divakaran, Anand; Johnson, Jorden A.; Buchholz, Caroline R.; Zahid, Huda; Vail, Nora R.; Shi, Ke; Aihara, Hideki; Harki, Daniel A.; Miller, Grover P.; Topczewski, Joseph J.; Pomerantz, William C.K.

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; National Institutes of Health (NIH)

OSTI ID:: 1818348

Journal Information:: J. Med. Chem., Vol. 64, Issue (14)

Country of Publication:: United States

Language:: ENGLISH

References (32)

Translating the Histone Code Jenuwein, T. Science, Vol. 293, Issue 5532 https://doi.org/10.1126/science.1063127	journal	August 2001
Spreading Chromatin into Chemical Biology Allis, C. David; Muir, Tom W. ChemBioChem, Vol. 12, Issue 2 https://doi.org/10.1002/cbic.201000761	journal	January 2011
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria Cell, Vol. 149, Issue 1 https://doi.org/10.1016/j.cell.2012.02.013	journal	March 2012
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers Lovén, Jakob; Hoke, Heather A.; Lin, Charles Y. Cell, Vol. 153, Issue 2 https://doi.org/10.1016/j.cell.2013.03.036	journal	April 2013
NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis Brown, Jonathan D.; Lin, Charles Y.; Duan, Qiong Molecular Cell, Vol. 56, Issue 2 https://doi.org/10.1016/j.molcel.2014.08.024	journal	October 2014
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E. Cell, Vol. 146, Issue 6 https://doi.org/10.1016/j.cell.2011.08.017	journal	September 2011
Brd4 Coactivates Transcriptional Activation of NF- B via Specific Binding to Acetylated RelA Huang, B.; Yang, X. -D.; Zhou, M. -M. Molecular and Cellular Biology, Vol. 29, Issue 5 https://doi.org/10.1128/MCB.01365-08	journal	December 2008
Clinical trials for BET inhibitors run ahead of the science Andrieu, Guillaume; Belkina, Anna C.; Denis, Gerald V. Drug Discovery Today: Technologies, Vol. 19 https://doi.org/10.1016/j.ddtec.2016.06.004	journal	March 2016
The bromodomain interaction module Filippakopoulos, Panagis; Knapp, Stefan FEBS Letters, Vol. 586, Issue 17 https://doi.org/10.1016/j.febslet.2012.04.045	journal	May 2012
Selective inhibition of BET bromodomains Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah Nature, Vol. 468, Issue 7327 https://doi.org/10.1038/nature09504	journal	September 2010
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology Ciceri, Pietro; Müller, Susanne; O'Mahony, Alison Nature Chemical Biology, Vol. 10, Issue 4 https://doi.org/10.1038/nchembio.1471	journal	March 2014
Systematically Mitigating the p38α Activity of Triazole-based BET Inhibitors Carlson, Angela S.; Cui, Huarui; Divakaran, Anand ACS Medicinal Chemistry Letters, Vol. 10, Issue 9 https://doi.org/10.1021/acsmedchemlett.9b00227	journal	August 2019
Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A) Seal, Jonathan; Lamotte, Yann; Donche, Frédéric Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 8 https://doi.org/10.1016/j.bmcl.2012.02.041	journal	April 2012
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression Gacias, Mar; Gerona-Navarro, Guillermo; Plotnikov, Alexander N. Chemistry & Biology, Vol. 21, Issue 7 https://doi.org/10.1016/j.chembiol.2014.05.009	journal	July 2014
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation Gilan, Omer; Rioja, Inmaculada; Knezevic, Kathy Science, Vol. 368, Issue 6489 https://doi.org/10.1126/science.aaz8455	journal	March 2020
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer Faivre, Emily J.; McDaniel, Keith F.; Albert, Daniel H. Nature, Vol. 578, Issue 7794 https://doi.org/10.1038/s41586-020-1930-8	journal	January 2020
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation Liu, Zhiqing; Chen, Haiying; Wang, Pingyuan Journal of Medicinal Chemistry, Vol. 63, Issue 10 https://doi.org/10.1021/acs.jmedchem.0c00035	journal	April 2020
Selective N‐Terminal BET Bromodomain Inhibitors by Targeting Non‐Conserved Residues and Structured Water Displacement** Cui, Huarui; Divakaran, Anand; Pandey, Anil K. Angewandte Chemie International Edition, Vol. 60, Issue 3 https://doi.org/10.1002/anie.202008625	journal	November 2020
Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C‐C Motif Chemokine Ligand 2–Mediated Angiocrine Signaling Gao, Jinhang; Wei, Bo; Liu, Mengfei Hepatology, Vol. 73, Issue 6 https://doi.org/10.1002/hep.31617	journal	April 2021
Discovery of N -Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1 H -pyrrolo[2,3- c ]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain Sheppard, George S.; Wang, Le; Fidanze, Steven D. Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.0c00628	journal	May 2020
Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype Wellaway, Christopher R.; Bamborough, Paul; Bernard, Sharon G. Journal of Medicinal Chemistry, Vol. 63, Issue 17 https://doi.org/10.1021/acs.jmedchem.0c00566	journal	August 2020
Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit Fish, Paul V.; Filippakopoulos, Panagis; Bish, Gerwyn Journal of Medicinal Chemistry, Vol. 55, Issue 22 https://doi.org/10.1021/jm3010515	journal	October 2012
Expanding the Medicinal Chemist Toolbox: Comparing Seven C(sp ² )–C(sp ³ ) Cross-Coupling Methods by Library Synthesis Dombrowski, Amanda W.; Gesmundo, Nathan J.; Aguirre, Ana L. ACS Medicinal Chemistry Letters, Vol. 11, Issue 4 https://doi.org/10.1021/acsmedchemlett.0c00093	journal	March 2020
Expanding the medicinal chemistry synthetic toolbox Boström, Jonas; Brown, Dean G.; Young, Robert J. Nature Reviews Drug Discovery, Vol. 17, Issue 10 https://doi.org/10.1038/nrd.2018.116	journal	August 2018
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?: Miniperspective Brown, Dean G.; Boström, Jonas Journal of Medicinal Chemistry, Vol. 59, Issue 10 https://doi.org/10.1021/acs.jmedchem.5b01409	journal	December 2015
Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode Lucas, Simon C. C.; Atkinson, Stephen J.; Bamborough, Paul Journal of Medicinal Chemistry, Vol. 63, Issue 10 https://doi.org/10.1021/acs.jmedchem.0c00021	journal	April 2020
The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules Talele, Tanaji T. Journal of Medicinal Chemistry, Vol. 59, Issue 19 https://doi.org/10.1021/acs.jmedchem.6b00472	journal	June 2016
Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase–Bromodomain Inhibitor Divakaran, Anand; Talluri, Siva K.; Ayoub, Alex M. Journal of Medicinal Chemistry, Vol. 61, Issue 20 https://doi.org/10.1021/acs.jmedchem.8b01248	journal	September 2018
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W. Advanced Drug Delivery Reviews, Vol. 64 https://doi.org/10.1016/j.addr.2012.09.019	journal	December 2012
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010

Similar Records

4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Imp

Journal Article · 2021 · J. Med. Chem. · OSTI ID:1815012

Cui, Huarui; Carlson, Angela S.; Schleiff, Mary A.; +11 more

Discovery of N -(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1 H -pyrrolo[2,3- c ]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor

Journal Article · 2017 · Journal of Medicinal Chemistry · OSTI ID:1414456

McDaniel, Keith F.; Wang, Le; Soltwedel, Todd; +29 more

Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9 H -pyrimido[4,5- b ]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor

Journal Article · 2017 · Journal of Medicinal Chemistry · OSTI ID:1373777

Zhao, Yujun; Bai, Longchuan; Liu, Liu; +13 more

4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Imp

Citation Formats

References (32)

Similar Records

Related Subjects